Welcome to the CPDD 2006 Conference. This slide show was prepared to recognize and celebrate the accomplishments of 128 award winners for 2006. Congratulations!
F. Ivy Carroll, Ph.D. Nathan B. Eddy Award As Director of Organic and Medicinal Chemistry and Distinguished Fellow at the Research Triangle Institute, my research studies have provided pharmacological tools and potential pharmacotherapies for substance abuse. We have developed compounds that target monoamine transporters, opioid receptors and nicotinic receptors and promise success as pharmacotherapies in addiction.
R. Christopher Pierce, Ph.D. Joseph Cochin Young Investigator Award I received a Ph.D. in neuroscience and psychology from Indiana University in 1993. I am currently Associate Professor of Pharmacology and Psychiatry at Boston University School of Medicine. My research focuses on the cellular and molecular mechanisms underlying cocaine craving using animal models.
Linda A. Dykstra, M.A., Ph.D. Marian W. Fischman Lectureship Award For over 30 years, I have led an active research program, focusing on the behavioral pharmacology of opioid analgesics, both in relation to their pain-relieving properties as well as their tendency to produce tolerance and dependence. A more recent research interest of my laboratory is the investigation of behavioral phenotypes related to substance abuse using genetically altered mice.
Joseph Frascella, Ph.D. J. Michael Morrison Award I am the Director of the Division of Clinical Neuroscience and Behavioral Research at NIDA, which covers a broad drug abuse and addiction program of translational research and research training in clinical neuroscience, human development, and behavioral treatment. I also served as the Chief of the Clinical Neurobiology Branch, and started my career at NIDA in the Neuroscience Research Branch with Roger Brown.
James C. Anthony, Ph.D. CPDD Mentorship Award I am conducting field studies to answer questions about the hazards of drug use in the U.S., four U.S. territories, and multiple countries (Latin America, Caribbean, Micronesia). My current research utilizes longitudinal designs with randomized interventions to study underlying susceptibility traits, conditions, and processes that influence rapid transitions through stages of drug involvement.
Richard M. Eisenberg, Ph.D. CPDD Distinguished Service Award I received my Ph.D. in 1970 from the U.C.L.A Department of Pharmacology. I just completed 29 years as Head of the Dept. of Pharmacology. In my career, I have studied opiate dependence/tolerance and now produce educational software. I am the Chair of the CPDD Electronics Committee.
Harvey Weiss, M.B.A. CPDD Media Award I am the Founder and Executive Director of the National Inhalant Prevention Coalition (NIPC), whose goal is to develop awareness and prevention campaigns to educate youth and adults about the debilitating effects of inhalants. Since its inception, the NIPC has received widespread media coverage, including feature stories in New York Times, and CNN Newsstand, and established National Inhalants and Poisons Awareness Week (NIPAW).
Jonathan B. Kamien, Ph.D. CPDD Distinguished Service Award At age ten, I decided to be an experimental psychologist. Seventeen years later, after receiving a BA from Middlebury College in 1982, I was awarded a Ph.D. from the University of Chicago in 1987. I have been studying the discriminative stimulus effects of drugs and behavioral treatments for drug dependence ever since.
Sara Jane Ward, Ph.D. CPDD Early Career Investigator Travel Award Mentors: Linda A. Dykstra, Ph.D., Ellen A. Walker, Ph.D . The cannabinoid CB1 receptor is a promising therapeutic target for drug addiction, obesity, and pain management. We study the role of the CB1 receptor in the reinforcing and rewarding properties of cocaine, morphine, and palatable foods using both behavioral pharmacology and genetic knockout mouse technology.
Project Metamorphosis is a four agency collaborative effort designed to engage and encourage homeless youth to exit street life with innovative outreach, and customized youth-friendly services integrating alcohol and drug and mental health treatment within a comprehensive approach.
Joshua A. Lile, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor: Thomas H. Kelly, Ph.D.
My study has found that estradiol enhances the discriminative-stimulus and subject-rated effects of d-amphetamine in females. These data support the notion that estradiol increases the sensitivity to the effects of psychostimulant drugs such as d-amphetamine in females.
Amy McCombs, MA, LCPC, CADC, MISA II, PCGC CSAT Travel Award
I am the Clinical Director of the Wells Center, a not-for-profit substance abuse treatment center in West Central Illinois. We provide detoxification, residential extended care, outpatient treatment and early intervention in the main facility in Jacksonville and in satellite offices and county probation offices in 8 nearby rural counties.
Ginger L. Becker, B.A. Primm-Singleton Minority Travel Award Mentor: Charles P. France, Ph.D.
My research focuses on the use of drug discrimination and other behavioral and physiological indices to characterize conditioned withdrawal and the extent to which conditioned withdrawal increases self-administration of drugs in morphine-dependent non-human primates.
William Fantegrossi, Ph.D. CPDD Early Career Investigator Award Mentors: Anthony L. Riley, Ph.D.; John R. Glowa, Ph.D.; James H. Woods, Ph.D.; Gail Winger, Ph.D.; Leonard L. Howell, Ph.D. My research examines drug effects in mice behavioral paradigms such as drug discrimination and food-maintained responding. In addition, I work with rhesus monkeys trained to self-administer hallucinogen-like drugs to gauge the effects of drug history on neural and behavioral endpoints, assessed via in vivo microdialysis, PET neuroimaging, and operant behavioral tasks.
Kathryn L. Hamilton, B.S. NIDA Director's Travel Award Mentor: Jonathan C. Gewirtz, Ph.D.
Opiate withdrawal produces affective and neuroendocrine changes, which negatively reinforce drug-taking behavior. My research is focused on characterizing the interaction between these two types of changes in a rodent model of methadone maintenance therapy.
Kate Vandegrift, MA, CAC, LPC CSAT Travel Award Mentor: Karol Kaltenbach, Ph.D.
I am the Program Director of MATER (Maternal Addiction Treatment Education and Research) at Jefferson Medical College, Philadelphia. We provide a continuum of care for drug- dependent pregnant and parenting women and their children. I am a Member of the Philadelphia Domestic Violence Task Force and the Pennsylvania Women’s Treatment Advocacy Consortium.
Ryan K. Lanier, Ph.D. NIDA Director's Travel Award Mentors: George E. Bigelow, Ph.D., Una D. McCann, M.D., and Eric C. Strain, M.D.
I am conducting clinical pharmacology studies of addiction pharmacotherapies, especially tramadol and new formulations of buprenorphine, and evaluating the neuropsychological sequelae of drugs of abuse such as ecstasy at the Johns Hopkins Behavioral Pharmacology Research Unit.
Allison V. Schlosser, B.S. NIDA Women & Gender Junior Investigator Travel Award Mentor: Catina L. Callahan, M.S.W.
As a MSW student focusing on women’s health, I am investigating the role that gender plays in the effective-ness of drug use prevention and treatment efforts, specifically focusing on highly vulnerable women. This knowledge will facilitate the tailoring of interventions to the specific needs of these women, ultimately making them more effective.
Sara K. Chase. M.A. CPDD Early Career Investigator Travel Award Mentor: Steven J. Ondersma, Ph.D.
Participant protection is vital in research involving stigmatized behaviors such as illicit drug use. My study compared disclosure of sensitive information under different consent conditions / levels of protection.
Christine M. Coyne, R.N., Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor: Dennis M. Donovan, Ph.D.
During recovery, physical and psychological symptoms diminish health and the quality of life for women and may impact the well-being of their families. I studied the change in craving and symptom experience over the course of early recovery and examined the impact of craving and symptoms on recovery outcomes in women.
Robert Leeman, Ph.D. NIDA Director's Travel Award Mentor: Stephanie O'Malley, Ph.D.
I am a NIDA Postdoctoral Fellow in Psychiatry at Yale University School of Medicine. My research interests include issues of disinhibition/ impulsivity and substance abuse, weight concerns and smoking and the synergy between alcohol use and smoking. I am about to begin a laboratory study to examine the effects of tobacco and food deprivation on smoking behavior.
Shanna Babalonis NIDA Women & Gender Junior Investigator Travel Award Mentor: Thomas H. Kelly , Ph.D.
I am currently exploring the manner in which hormones affect the behavioral and pharmacological mechanisms of drugs of abuse. Specifically, I am interested in hormonal modulation of the reinforcing and discriminative stimulus effects of certain drugs, with a focus on the modification of delay discounting functions.
Rebekka S. Palmer, Ph.D. CPDD Early Career Investigator Travel Award Mentor: Samuel A. Ball, Ph.D.
My research focuses on prevention and treatment of substance abuse and addictive behaviors among high risk populations. I have examined the prevalence of alcohol, drug (illicit and prescription), and tobacco use as well as gambling and sexual victimization. I will evaluate the relationship between students’ drug use, number of negative consequences due to their use, and level of interest in an intervention and modality.
Lynn M. Anderson, M.S. NIDA Women & Gender Junior Investigator Travel Award Mentor: Dace S. Svikis, Ph.D.
My research interests include tobacco use and dependence in special populations such as adolescents and pregnant women. My dissertation will focus on the validity of self-reported smoking behaviors in pregnant women.
Randall E. Rogers, Ph.D. NIDA Director's Travel Award Mentor: Stephen T. Higgins, Ph.D.
My training is in clinical health psychology and I am studying voucher-based reinforcement therapy with cocaine abusers. One of my research interests is the relationship between substance use and involvement in healthier, non-drug related activities in the natural environment. I am also interested in behavioral treatments for drug abuse.
Wendy Beth Bostwick, Ph.D., M.P.H. NIDA Women & Gender Junior Investigator Travel Award Mentor: Sean Esteban McCabe, Ph.D., M.S.W.
I am a recent graduate in Public Health and am interested in the epidemiology of substance use, particularly among sexual-minority women. In addition, my work explores the connection(s) between discrimination, stigma and substance use and mental health outcomes among lesbian, gay, bisexual and transgender populations.
Through my experience in the substance abuse field, I have found that enhancing and implementing brief intervention services to college populations has been the most effective and rewarding work for me. I believe that by providing brief intervention services to this population, we are possibly interrupting the path to addiction.
Vinita Batra NIDA Women & Gender Junior Investigator Travel Award Mentor : Dr. Lisa Schrott, Ph.D.
Oxycodone is an opioid analgesic used to alleviate mild to moderate pain. Being an opioid derivative in nature, its abuse potential has emerged significantly in U.S. My study focuses on the reproductive effects of chronic oxycodone treatment in female rats.
Kelly E. Dunn, Ph.D. NIDA Director's Travel Award Mentor: Stacey C. Sigmon, Ph.D. I am currently using contingency management to promote smoking cessation in methadone-maintained patients. I am also working to develop and evaluate the efficacy of a buprenorphine/ naltrexone therapy to treat prescription opioid addiction. I am interested in learning how to apply human behavioral pharmacological techniques to facilitate drug abstinence.
Bethea A. Kleykamp, M.A. NIDA Women & Gender Junior Investigator Travel Award Mentor : Thomas E. Eissenberg, Ph.D. Cognitive performance is impaired by tobacco abstinence and reinstated by smoking or nicotine replacement therapy (e.g., transdermal nicotine; TN). My study examined potential gender differences in the cognitive effects of smoking and TN in overnight-abstinent smokers.
Terry-Lee Howard, M.P.H. Primm-Singleton Minority Travel Award Mentor: Robert J. Jagers Ph.D.
Adolescent substance use is a pressing public health concern, especially for African American youth. My study will use baseline data from the Aban Aya Youth Project, to examine the co-occurrence of early substance use, violence and sexual behaviors among urban African-American fifth grade boys and girls.
Matt W. Feltenstein, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor : Ronald E. See, Ph.D. Clinical research suggests that gender differences exist in cocaine dependence. Using a preclinical model, my research has focused on the role of the estrous cycle and hormonal influences on cocaine self-administration and cocaine-primed reinstatement of drug- seeking behavior.
Glenn R. Valdez, Ph.D. CPDD Early Career Investigator Travel Award Mentor: Roger D. Spealman, Ph.D.
Stress appears to play a key factor in relapse to drug abuse. The neurobiological mechanisms underlying regulation of stress-related relapse are still unclear. My research focuses on interactions between corticotrophin-releasing factor, kappa opioids, and norepinephrine in the reinstatement of cocaine-seeking behavior.
Amy A. Mericle, Ph.D. NIDA Director's Travel Award Mentor: Barbara E. Havassy, Ph.D. I am a graduate of the University of Chicago and currently am a post-doctoral fellow at the San Francisco Treatment Research Center (TRC) at the University of California. My research interests include co-occurring substance use and mental disorders, HIV/AIDS risk behaviors, and social networks.
The House of Hope and Horizon House in Columbia, S.C., serve the homeless who suffer from mental illness and are dually diag-nosed with a substance abuse disorder. The center provides services ranging from medical care to recreational therapy. I supervise and guide a multi-disciplinary staff; assess needs; coordinate staff and partner organization training; and develop policies for program implementation.
Kathleen Ragsdale, Ph.D. NIDA Director's Travel Award Mentors: Bruce D. Johnson, Ph.D. and Gregory Falkin, Ph.D. Increases in more extreme forms of college drinking (e.g., binging) are reported. We have found that, while a random sample of college students did not differ by gender according to drinking, Greek-affiliated males were significantly more likely to report engaging in physical fights, while Greek-affiliated females were significantly more likely to report being taken advantage of sexually and engaging in unwanted sex.
Chiquitia L. Welch, MSSA, MPA Primm-Singleton Minority Travel Award Mentor: Amelia Roberts, Ph.D.
The focus of my dissertation research is to develop research-based profiles of incarcerated adolescent females with substance use disorders. The aim is to inform targeted interventions and specific treatment approaches for incarcerated adolescent females with histories of substance misuse, substance use disorders, and serious delinquency.
Carlos F. Rios-Bedoya, M.P.H., Sc.D. NIDA Director's Travel Award Mentor: James C. Anthony, Ph.D. I am studying the transition from “opportunity to try” to actual first use of drugs in adolescents by assessing parental monitoring, deviant peer affiliation, academic achievement, neurodevelopmental and genetic factors with special attention to ethnic differences. With colleagues from Central, South America, and the Caribbean we will further examine cultural and regional differences.
Evan L. Riddle, Ph.D. CPDD Early Career Investigator Travel Award Mentor: Annette E. Fleckenstein, Ph.D.
Psychostimulants potently alter dopamine signaling. My research centers on the effects that these agents exert on the activity and subcellular co-localization of neurotransmitter transporters and the association of these effects with the neurotoxic consequences of high-dose methamphetamine administration.
Kipling M. Bohnert NIDA Women & Gender Junior Investigator Travel Award Mentor : James C. Anthony, Ph.D. I am a pre-doctoral fellow in Dr. Anthony’s Drug Dependence Epidemiology Training Program at Michigan State University. My research focuses on the epidemiology of cannabis and analgesic dependence.
I am the Director of Clinical Treatment Services at CAB Health & Recovery Services in MA. I oversee and improve the quality of treatment delivered across CAB’s continuum. I am a faculty member in Psychiatry at Harvard Medical School, have been PI of a number of CSAT and CDC grants and write a weekly newspaper column in which I respond to questions about addiction.
Brian S. Fulton Ph.D. NIDA Director's Travel Award Mentor: John L. Neumeyer Ph.D. I am currently focused on the synthesis and study of new ligands that bind selectively to opioid receptors for the treatment of cocaine abuse and dependence. We are interested in the synthesis and pharmacology of morphinan-based bivalent ligands that are selective agonists at mu/kappa receptors and their use to explore receptor dimerization in addiction processes.
Emma Childs, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor : Harriet de Wit, Ph.D. One way in which acute stress may affect drug-taking behavior is by directly altering the physiological and/or subjective effects of drugs. Our study was designed to characterize the time-course of physiological, psychological and hormonal responses to acute stress in men and women and in smokers and nonsmokers.
Venusha Moodley, M.P.H. NIDA Director's Travel Award Mentor: Emmalee S. Bandstra, M.D. My research career has enabled me to work with adolescents who may have been prenatally exposed to cocaine. Substance abuse continues to negatively impact the growth and development of children. I hope to expand the scope of my research to include interventions geared toward the prevention of problems that arise from the cyclical nature of drug abuse.
Jennifer L. Newman, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor : Marilyn E. Carroll, Ph.D. Examining factors that mediate the reinforcing effects of drugs is critical for developing effective treatment approaches. My research focuses on the role of ovarian steroid hormones and other pharmacological mechanisms influencing drug self-administration.
David E. Moorman, Ph.D. NIDA Director's Travel Award Mentor: Laura L. Peoples, Ph.D. I am interested in understanding the cellular basis of the plasticity underlying cocaine addiction. I am recording from single neurons in the rat orbitofrontal cortex during cocaine and sucrose self-administration to investigate how such neural activity contributes to drug-seeking and taking behaviors and to understand how dysfunction of the area may be involved in drug addiction.
Teresa J. Linares Scott, M.A. Primm-Singleton Minority Travel Award Mentor: Lynn T. Singer, Ph.D.
Prenatal substance exposure can have a lasting impact on children's development. I evaluated aggressive behaviors in a large sample of cocaine-exposed children who were 9 years of age at assessment. I continue working with children and mothers impacted by maternal substance use during pregnancy, focusing specific-ally on mental health outcomes.
Jennifer R. Havens, Ph.D., M.P.H. NIDA Women & Gender Junior Investigator Travel Award Mentor : Carl G. Leukefeld, D.S.W. My research interests include the epidemiology of prescription opioid misuse, drug use among pregnant women, and comorbid psychopathology among drug users.
Noosha Niv, Ph.D. NIDA Director's Travel Award Mentors: Yih-Ing Hser, Ph.D. and Rick Rawson, Ph.D. Current projects include the development of a cognitive-behavioral intervention for comorbid substance abuse and psychotic disorders and an analysis of ethnic differences in utilization of mental health services and outcomes among drug-abusing patients with mental health problems.
Sarah Church, Ph.D. CSAT Travel Award Mentor: Ira J. Marion, M.A.
I am the Associate Executive Director of the Division of Substance Abuse at the Albert Einstein College of Medicine. I am currently in an administrative role, but in previous positions I conducted research to develop novel psychosocial and psychopharmacological interventions for opioid and cocaine dependence.
Samuel A. Roiko, B.S. NIDA Director's Travel Award Mentor: Paul Pentel, M.D. Immunotherapy provides a new strategy to treat addiction by targeting the drug rather than the brain. My thesis project is focused on the effects of passive immunization (using nicotine-specific monoclonal antibodies) on nicotine pharmacokinetics and behaviors relevant to nicotine addiction in rats.
Elizabeth K. Reynolds NIDA Women & Gender Junior Investigator Travel Award Mentor : Carl Lejuez, Ph.D. I am currently studying the role of theoretically relevant personality (i.e., negative emotionality, and impulsivity) and environmental (history of sexual abuse) variables as potential underlying mechanisms (i.e., mediators) of the relationship between gender and drug choice among patients in an inner-city residential substance abuse treatment program.
Laura L. Chivers, B.A. NIDA Director's Travel Award Mentor: Stephen T. Higgins, Ph.D. My current research focus is early abstinence and the influence of non-pharmacological factors on drug self-administration. My project examines the influence of duration of abstinence and of programmed smoking lapses on withdrawal and related participant ratings and on the relative reinforcing effects of smoking.
I am the Executive Director of a residential treatment program for adult males. I have worked in the addiction field for twenty-six consecutive years. In my spare time I am active as a trainer and wish-granter for the Make-A-Wish Foundation of New Jersey.
Laurence L. Miller, M.A. NIDA Director's Travel Award Mentor: Linda A. Dykstra, Ph.D. The glutamate system has been shown to play a role in the behavioral effects of opioids. I am studying mice with a partial deletion of the NR1 subunit of the NMDA receptor as a way to examine the involvement of the glutamate system in several effects of morphine, in particular its rewarding effects as displayed in the conditioned place preference procedure.
Trudy A. Smith Primm-Singleton Minority Travel Award Mentor: Andrew Coop, Ph.D.
Prescription opioid analgesics suffer from the side effects of tolerance and dependence. My research is focused on the design and synthesis of analogs that reduce/eliminate these side effects.
Ty S. Schepis, B.S. NIDA Director's Travel Award Mentor: Uma Rao, M.D. My current research is focused on smoking cessation for adolescents, particularly in subgroups of adolescents, such as those with a history of depression. In addition, I am interested in prescription stimulant abuse and diversion, and I am currently examining the availability of stimulants without a prescription via the Internet.
Justin J. Anker NIDA Women & Gender Junior Investigator Travel Award Mentor : Marilyn E. Carroll, Ph.D I am interested in endogenous factors that influence various phases of the drug addiction process. My studies examine the effects of progesterone and estrogen on the reinstatement of cocaine seeking, and the interaction between sex, saccharin preference, and impulsivity on the self-administration of cocaine in female rats.
Sel J. Wahng, Ph.D. NIDA Director's Travel Award Mentor: Larry Nuttbrock, Ph.D. Focusing on male-to-female transgendered persons in New York City, I am conducting a quantitative epidemiological longitudinal initiative measuring gender identity, identity development, substance use, depression, and HIV/STD risk factors. I am also performing a self-initiated qualitative investigation examining African Americans, Latina/os, and Asians in relation to HIV/STD risk behaviors.
Kevin P. Hill, M.D. CPDD Early Career Investigator Travel Award Mentor: Mehmet Sofuoglu, M.D. Ph.D.
As a Robert Wood Johnson Clinical Scholar at Yale, I study the effects of atomoxetine on stress response in healthy subjects. The attenuation of responses to physiological, psycho-logical, and pharmacological stressors may provide a rationale for further study of noradrenergic medications as treatments for stimulant addiction.
Jeffery C. Batis NIDA Women & Gender Junior Investigator Travel Award Mentor : Scott Bowen, Ph.D. My studies examine the biobehavioral sequelae associated with inhalant abuse as a function of age at time of exposure. My research has revealed that earlier exposure, particularly during the prenatal or adolescent stages, leads to a variety of adverse outcomes not seen in adult animals given equivalent exposures.
I am the Program Director of Outpatient Services at Jackson Recovery Centers in Sioux City, Iowa. I am responsible for clinical programs that service over 2000 patients per year. My responsibilities include marketing, developing and managing budgets for 8 clinical programs, staff supervision, and program development and implementation.
Andrea H. Weinberger, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor : Tony P. George, M.D. My research focuses on combining pharmacological and behavior treatments for nicotine dependence to improve cessation outcomes and prevent or delay relapse to smoking. My study investigates gender differences in smoking expectancies for smokers in a pharmacological trial of Selegiline (an MAO-B inhibitor) for smoking cessation.
My current research centers on the cultural and ethnic factors associated with adolescent substance use. My most recent work focuses on ethnic disparities in the utilization of substance abuse treatment services among California’s Proposition 36 clients.
Stacey B. Daughters, Ph.D. CPDD Early Career Investigator Travel Award Mentor: C.W. Lejuez, Ph.D.
My research focuses on distress tolerance as a predictor of early treatment dropout and relapse across addictive disorders as well as the development and persistence of substance use among adolescents. I also use behavioral activation strategies in the context of standard substance abuse treatment for patients with elevated depressive symptoms.
Susie Ruiz, J.D., L.M.S.W., M.A.C., C.C.J.A.P. CSAT Travel Award Mentor: Emmitt Hayes, Jr.
As the Clinical Case Work Manager for the Juvenile Justice Integrated Network, I supervise a day treatment program and the respective counselors/staff. I have been instrumental in the development of the Department multidisciplinary staffing process which allows for identification of client strengths and needs .
Marc L. Copersino, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentors: Roger D. Weiss, M.D.; David A. Gorelick, M.D., Ph.D. There are few data on the experience of spontaneous cessation of cannabis use in adults, especially with regard to the effects of gender. I examined gender differences in retrospectively self-reported characteristics of spontaneous cannabis quitting among non-treatment-seeking, adult cannabis smokers.
Brian O. Butler, M.S., L.P.C. CSAT Travel Award Mentor: Sonia Jackson
I am currently expanding substance abuse programming to better serve co-occurring- disordered populations, gender-specific substance abuse treatment for women with dependent children, and substance-abusing, pregnant women. I research and develop innovative, evidenced-based treatments for returning combat-zone veterans in acute treatment settings.
Deborah John Rinehart, M.A. NIDA Women & Gender Junior Investigator Travel Award Mentor: Karen Fortuin Corsi, Sc.D., M.P.H. HIV among women is an increasing public health concern. My study investigated gender differences in a group of injection drug users and found that more women are engaging in risky injection and sex behaviors when compared to men. In addition, regression analyses identified variables related to HIV risk behaviors for women.
Joanne Kurt-Hilditch, BSCJ, CSAC II CSAT Travel Award
I am the Quality Assurance Director for the Kansas City Community Center, a non-profit organization that provides substance abuse treatment services in prisons and the community throughout Missouri. I devise and implement curricu-lum and update resources, ensuring compliance with mandated State standards and ensuring appropriate care for our clientele.
Matthew J. Carpenter, Ph.D. CPDD Early Career Investigator Travel Award Mentor: Himanshu Upadhyaya, M.B.B.S., M.S.
In laboratory-based investigations of cue reactivity, nicotine-dependent individuals report high levels of craving in response to tobacco-related cues. It is unclear whether individuals' responses to cues extinguish over repeated laboratory sessions. Our study examines the persistence of cue
reactivity across multiple experimental sessions.
Kevin T. Ball, B.A. NIDA Director's Travel Award Mentor: George V. Rebec, Ph.D. My research focuses on the neural mechanisms underlying changes in behavior following exposure to drugs of abuse. I have focused on the effects of the popular club drug MDMA (ecstasy) on brain and behavior. Results from these investigations have revealed that MDMA exposure is associated with enduring behavioral and neuronal plasticity in striatum.
Qi Wan, M.D. CPDD Early Career Investigator Travel Award Mentor: Wen-Zhe Ho, M.D.
Opioids and Substance P are potent modulators of neuro-immunoregulation. The biological interaction of opioids, Substance P and the neurokinin-1 Receptor (NK-1R) pathway is of particular interest. Our research is focused on the effects of morphine on expression and function of NK-1R in the central nervous system.
Konstantin Dumchev, M.D., M.P.H. WHO/NIDA/CPDD International Travel Award Mentor: Joseph E. Schumacher, Ph.D. I am currently a physician at Methodology & Statistics Core, Vinnitsya Regional Narcological Dispensary, Vinnitsya, Ukraine. My research interests include opiate dependence, treatment, blood-borne infections. Recently I have studied predictors of HIV and HCV status in IDUs in Vinnitsya, Ukraine, and transporting behavioral treatment for opiate IDUs in Ukraine.
Katherine Keyes, B.A. NIDA Women & Gender Junior Investigator Travel Award Mentor: Deborah Hasin, Ph.D. I am an Assistant Research Scientist working on projects involving the National Epidemiologic Survey on Alcohol and Related Conditions and other large-scale datasets. Concurrently, I am pursuing an MPH in epidemiology from Columbia University, and was recently awarded a pre-doctoral fellowship in psychiatric epidemiology to continue my studies at the doctoral level.
I bring 35 years of experience providing substance abuse treatment and prevention services to a four-county, rural area of Southeast Iowa. Services include ASAM Levels I through III.7 in the context of a modified therapeutic community.
Jin H. Yoon, Ph.D. NIDA Director's Travel Award Mentor: Stephen T. Higgins, Ph.D. I am currently working with pregnant women in a clinical-outcomes-based research center. One general area of research interest is the relationship between delay discounting and drug abuse. Additionally, I am also interested in contingency management and its role in facilitating drug treatment.
Nehal P. Vadhan, Ph.D. CPDD Early Career Investigator Travel Award Mentor: Richard W. Foltin, Ph.D.
I employ neuropsychological and behavior pharmacological methods to study learning ability and executive function of cocaine and marijuana abusers under conditions of abstinence and intoxication. Knowledge of the long-term cognitive effects of these drugs will assist in the development of more effective cognitive-behavioral treatments.
Glenda Springsted-Spencer, M.A. CSAT Travel Award
I am the Director of Addiction Services at a residential treatment program in Cando, ND. My project was to develop the Center for Solutions Alumni Association and a website that provides the Alumni with the means of maintaining ongoing relationships. I love to learn and am excited to explore the latest information in blending research and addiction treatment.
Erica Peters, B.A. NIDA Director's Travel Award Mentor: John Hughes, M.D. I am a predoctoral student investigating the natural history of reduction and cessation attempts by tobacco smokers. I am investigating the efficacy of gradual vs. abrupt smoking cessation, the rate of relapse to smoking after one year of abstinence, and the natural history of attempts by marijuana users to quit. I plan to study the effect of marijuana abstinence on the use of other drugs.
Shane A. Perrine, Ph.D. CPDD Early Career Investigator Travel Award Mentor: Ellen M. Unterwald, Ph.D.
I study the neuropharmacological and behavioral effects of cocaine, focusing on dopamine and opioid signaling and interactions. I have found that 1-day withdrawal from chronic binge-pattern cocaine desensitized delta-opioid receptors in rat striatum and increased anxiety- and depression-like measures, behaviors that are blocked by pretreatment with the delta-opioid agonist SNC-80.
Min Zhao, M.D., Ph.D. WHO/NIDA/CPDD International Travel Award Mentor: Walter Ling, M.D. My research interests include genetic, clinical and intervention influences on craving and drug dependence and HIV, HCV and other infectious diseases among IDUs. I am actively involved in an international collaboration between China and other countries.
I provide both residential and outpatient treatment services to adolescents and adults. Currently, my focus is on providing services to residents in a rural area of South Texas where minimal resources are available. I am the Program Director of an Outpatient Treatment program for the Brush Country Council on Alcohol & Drug Abuse in Floresville, Texas.
Karen F. Corsi, Sc.D., M.P.H. CPDD Early Career Investigator Travel Award Mentor: Robert E. Booth, Ph.D.
Methamphetamine is a serious and growing problem in the U.S. People who use methamphetamine are at risk for a host of health problems and diseases, including HIV and Hepatitis C. My study investigated injection drug users who use meth and found that they are at high risk for HIV due to their risky injection practices.
I am a Master’s Level Licensed Addictions Counselor, Administrator of Acadiana Recovery Center and owner of HERS L.L.C. I am a certified Clinical Supervisor and Crisis Prevention Supportive Intervention Instructor, President Elect of the Louisiana Association of Substance Abuse Counselors and Trainers and the recipient of the 2005 Louisiana Counselor of the Year Award.
Jay Elliott, Ph.D. CPDD Early Career Investigator Travel Award Mentor: Ronald E. See, Ph.D.
My project sought to explore potential mechanisms through which the dorsal striatum structure influences the expression of cocaine-seeking behavior. I evaluated the role of dopamine D1 and ionotropic glutamate receptors in the dorsolateral caudate/putamen as mediators of relapse in a rat model of reinstatement.
Patricia. A. Woicik, Ph.D. NIDA Director's Travel Award Mentor: Rita Z. Goldstein, Ph.D. My study examined relationships between personality and performance-based measures of inhibitory control in cocaine abusers. Results from this research suggest that drug-addicted individuals who report greater positive emotionality and self-control may in fact have impaired insight to their deficits.
I direct chemical dependency programs for a regional mental health center, including a 54-bed residential unit for adults (including pregnant and parenting women), and a 24-bed adolescent residential center. I wrote the initial grants for these programs. I write articles and books on chemical dependency and spirituality.
Sabrina Ford, Ph.D. NIDA Director's Travel Award Mentor: Hallam Hurt, M.D. Risk behaviors in adolescents, such as drug use, conduct problems, and high-risk sex are serious and may lead to adverse health outcomes later in life. My research involves the exploration of neurocognitive correlates of such risk behaviors in an effort to inform regarding prevention and treatment measures.
Rinah T. Yamamoto, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor: Marc J. Kaufman, Ph.D. Among chronic cocaine abusers, males are more vulnerable than females to cocaine’s adverse brain and vascular effects. My study investigated physiological, pharmacokinetic, and behavioral responses to the combined effects of IV cocaine and altered gonadal hormone status in cocaine-using men.
James Willis, Sr, MS, LPC, LSATP CSAT Travel Award
I am the Program Director for the Substance Abuse Therapeutic Community Program for incarcerated males (Chesapeake, VA). By utilizing client evaluations in the clinical assessment, we are capturing data to enhance program efficiency. Our research provides the opportunity to clearly measure treatment necessities, clarify remaining treatment needs and target areas of focus in the last phase of treatment.
Gregory Breeden, Ph.D., M.P.H. NIDA Women & Gender Junior Investigator Travel Award Mentor: Margaret Ensminger, Ph.D. My dissertation research investigated factors that determined perceptions of racial discrimination, their impact on frequency of cocaine and marijuana drug use, and gender differences in these factors. I am currently continuing my research as the Paul B. Cornely Postdoctoral Scholar at the Center for Research on Ethnicity, Culture and Health (CRECH) at the University of Michigan.
Arpana Agrawal, Ph.D. CPDD Early Career Investigator Travel Award Mentors: Pamela A.F. Madden, Ph.D.; Andrew C. Heath, D.Phil.
My research focuses on the genetic epidemiology of cannabis use, abuse and dependence. This year, I present findings from a study of 13 genetic models of comorbid cannabis and other illicit drug use and problems. I also study the role of genomic regions and candidate genes for cannabis and other illicit drug use disorders.
Wendy Donlin, Ph.D. NIDA Director's Travel Award Mentor: Kenneth Silverman, Ph.D. As a post-doctoral fellow in the Behavioral Pharmacology Research Unit at the Johns Hopkins School of Medicine, I am examining the efficacy of employment-based reinforcement interventions on drug abstinence and ingestion of naltrexone. I am interested in conducting research on the use of contingency management interventions for treating drug abuse.
Sylvia Fitting, M.A. CPDD Early Career Investigator Travel Award Mentors: Charles F Mactutus, Ph.D. & Rosemarie M Booze, Ph.D.
Neurological complications continue to be manifest in the HIV-1 type 1-infected population. Focusing on NeuroAIDS, my research examines developmental neurotoxic effects of the HIV-1 proteins, Tat and gp120, on neurobehavioral and anatomical measures in an animal model.
Jermaine Jones, M.S. Primm-Singleton Minority Travel Award Mentor: Anthony L. Riley, Ph.D.
Most commonly abused drugs have rewarding and aversive properties which both contribute to their abuse liability. My research focuses on the pharmacological basis of the aversive affective properties of cocaine, with specific concentration on the role of dopamine, norepinephrine and serotonin transporter inhibition.
I am the Clinical Director of Life Guidance Services, a division of Proaction Behavioral Health Alliance of Grand Rapids, Michigan. Current duties include professional development of clinical staff through training and supervision, especially in co-occurring Disorders, Motivational Interviewing and Evidence-based Practice, as well as program design and implementation.
Lawrence P. Carter, Ph.D. CPDD Early Career Investigator Award Mentor: Roland R. Griffiths, Ph.D. Gamma-hydroxybutyrate (GHB) is a putative neurotransmitter, a drug of abuse, and a novel therapeutic for narcolepsy. My previous research helped identify and characterize pharmacological mechanisms of action of GHB using behavioral procedures in rodents. My current research examines the abuse liability and cognitive effects of GHB in human volunteers.
I am the Clinical Director for a Behavioral Health Network in New Mexico which serves the Native American communities. I received my doctorate degree in Clinical Psychology in 1999, but have worked in the addictions and mental health fields for 20 years. My areas of expertise are the treatment of adults with co-occurring disorders, esp. mental health and addiction.
Jeffrey S. Gonzalez, Ph.D. NIDA Director's Travel Award Mentor: Steven A. Safren, Ph.D. I study psychosocial approaches to treatment adherence issues in chronic illness, especially HIV. I am currently conducting a randomized clinical trial to examine the efficacy of a cognitive behavioral therapy intervention to improve medication adherence and decrease depression in HIV+ patients on methadone maintenance. The data will inform the adaptation of this intervention for use with HIV+ monolingual Latinos.
Brian C Kelly, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor: Jeffrey T Parsons, Ph.D. I am a medical anthropologist studying drug use, sexual health, and youth cultures. I conduct research in the New York City metropolitan area and the foci of my current projects include club drug use among NYC metropolitan area young adults, drug dealing among suburban youth, and the emerging trend of tryptamine use.
Jesse Jong-Shik Suh, Psy.D. NIDA Director's Travel Award Mentor: Anna Rose Childress, Ph.D. My research has demonstrated that lower resting perfusion in the anterior cingulate cortex predicts increased depressive symptoms in treatment-seeking cocaine patients, pointing to a potential source of relapse vulnerability. My ongoing work is focused on novel brain-behavioral probes of affect dysregulation in adult substance abusers and in adolescents at risk for addiction.
Benjamin P. Kowal, Ph.D. NIDA Women & Gender Junior Investigator Travel Award Mentor: Warren K. Bickel, Ph.D. My studies demonstrated that females tend to discount temporally distant rewards less than males across reward classes (i.e., money and cigarettes) and direction in time (i.e., past gains or future gains). Different survival goals may influence differences in temporal discounting among males and females.
Wei Hua, M.D., M.S., M.H.S. NIDA Director's Travel Award Mentor: Carl Latkin, Ph.D. My research focuses on HCV mono-infection and its co-infection with HIV, as well as specific risk behavior patterns, among injection drug users in a social network context. Such knowledge may provide insight into HCV transmission dynamics in the era of HIV and may direct appropriate HIV/HCV combined prevention intervention efforts.
Mary A. Hatch-Maillette, Ph.D. CPDD Early Career Investigator Award Mentors: Donald A. Calsyn, Ph.D. I am a Research Scientist at the University of Washington Alcohol and Drug Abuse Institute. My research and clinical interests include substance abuse, HIV/AIDS, gender specific addiction treatment, and PTSD. Since 2003, I have overseen NIDA-funded clinical trials at treatment programs in Washington state and nationally.
I am the Project Director for the Moving On Program at LUK, Inc, and Director of LUK's Behavioral Health Clinic. I work with our local child welfare agency to implement an extension of MET/CBT5 utilizing another evidenced-based model Assertice Continuing Care (ACC), an outreach case management model intended to sustain and supplement gains made in substance abuse treatment.
Danielle E. Ramo, M.S. CPDD Early Career Investigator Award Mentor: Sandra A. Brown, Ph.D.
I am currently studying whether a diagnosis of depression while in inpatient substance abuse treatment or more proximal depression symptoms are associated with relapse. Results reveal that proximal symptoms, rather than a diagnosis of depression, put youth at risk for relapse after treatment.
I direct an on-campus state- accredited alcohol and drug treatment program. Since 1998 we have trained about 6600 students in the identification and management of Alcohol Poisoning, and we have initiated Drunk – Drugged – Driving programs and have reduced DWI’s in our target population of USD students by over 35% in 3 years.